About Ampliqon
Ampliqon is a company based in Odense (Denmark) founded in 2002. It operates as a B2B. The company has 25 employees. Ampliqon offers products and services including PCR Enzymes, Taq DNA Polymerases, Laboratory Reagents, and PCR Kits. Ampliqon operates in a competitive market with competitors including Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
- Headquarter Odense, Denmark
- Employees 25
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ampliqon.com
- Social LinkedIn
- Legal Name Ampliqon A/S
- Employee Count25
Products & Services of Ampliqon
Ampliqon offers a comprehensive portfolio of products and services, including PCR Enzymes, Taq DNA Polymerases, Laboratory Reagents, and PCR Kits.
Enzymes for DNA amplification in molecular biology research
Polymerases for endpoint PCR and genotyping applications
Custom buffers and solutions for lab experiments
Kits for real-time PCR and DNA extraction processes
Competitors of Ampliqon
Ampliqon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| oncodna.com | 2012 | Charleroi, Belgium | $44.53M | 37 | Genomic and theranostic services for oncology precision medicine are delivered. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| diagenode.com | 2003 | Seraing, Belgium | $8.45M | 99 | Reagents and kits for epigenetics sequencing solutions are developed. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders |
Detailed competitors of Ampliqon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ampliqon
Websites that share an audience with Ampliqon (ampliqon.com).
Websites whose visitors overlap most with Ampliqon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioatlas.com | 98% | – | – | View details |
Similar companies to Ampliqon
10 companies that operate in the same segment as Ampliqon (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ampliqon
Ampliqon was founded in 2002.
Ampliqon is headquartered in Odense, Denmark.
Ampliqon has 25 employees.
Ampliqon is a Danish company based in Odense that specializes in manufacturing high-quality PCR enzymes, DNA polymerases, buffers, and custom laboratory reagents. They supply standard and tailored products to hospitals, universities, research institutions, and life-science industries worldwide. Operating through distributors, they focus on reliable solutions for molecular biology and chemical needs, ensuring extensive technical support and quick delivery.
Ampliqon's top competitors include Abcam, Sino Biological and OncoDNA.
Ampliqon offers PCR Enzymes, Taq DNA Polymerases, Laboratory Reagents, and PCR Kits.
Ampliqon operates through Ampliqon A/S.